Department of Geratology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Shandong, China.
Adv Nutr. 2021 Dec 1;12(6):2255-2264. doi: 10.1093/advances/nmab074.
The results from epidemiologic studies suggest that vitamin D receptor (VDR) gene polymorphisms are potentially associated with Alzheimer disease (AD) and mild cognitive impairment (MCI), but this association has yet to be confirmed. Here, we conducted a meta-analysis based on a larger sample size to clarify the contribution of VDR gene polymorphisms to MCI and AD susceptibility. The PubMed, Embase, Cochrane Library, and China National Knowledge Infrastructure databases were searched to obtain studies published before 30 October, 2020. The case group includes MCI and AD patients, and the matched controls were without any cognitive complaints. ORs and 95% CIs were used to assess the strength of the association. Ten case-control studies with 3573 participants and 4 loci of ApaI rs7975232, BsmI rs1544410, FokI rs10735810, and TaqI rs731236 were included in the meta-analysis. The global assessment indicated an association between the BsmI polymorphism and increased odds of MCI in the allelic model (b compared with B; OR: 1.77; 95% CI: 1.24, 2.54), the dominant model (bb + Bb compared with BB; OR: 2.04; 95% CI: 1.32, 3.16), and the heterozygote model (Bb compared with BB; OR: 1.97; 95% CI: 1.26, 3.09). In contrast, the ApaI polymorphism was protective against MCI in all models. The dominant model (tt + Tt compared with TT; OR: 1.44; 95% CI: 1.17, 1.79) and the homozygous model (tt compared with TT; OR: 1.43; 95% CI: 1.02, 2.00) revealed an association between the TaqI polymorphism of the VDR gene and increased odds of AD, particularly for Caucasian subjects. Egger's linear regression test found no publication bias. This meta-analysis indicated that VDR ApaI and BsmI, and TaqI gene polymorphisms may be important predictors of MCI and AD, respectively, with population discrepancies. More research is needed to further confirm these associations, especially considering gene-gene interactions, gene-environment interactions, and other confounding factors.
流行病学研究的结果表明,维生素 D 受体(VDR)基因多态性可能与阿尔茨海默病(AD)和轻度认知障碍(MCI)有关,但这种关联尚未得到证实。在这里,我们进行了一项荟萃分析,以更大的样本量来阐明 VDR 基因多态性对 MCI 和 AD 易感性的贡献。我们检索了 PubMed、Embase、Cochrane 图书馆和中国国家知识基础设施数据库,以获取截至 2020 年 10 月 30 日之前发表的研究。病例组包括 MCI 和 AD 患者,匹配的对照组没有任何认知主诉。OR 和 95%CI 用于评估关联的强度。纳入了 10 项病例对照研究,共 3573 名参与者和 4 个位点的 ApaI rs7975232、BsmI rs1544410、FokI rs10735810 和 TaqI rs731236。荟萃分析结果显示,BsmI 多态性与等位基因模型(与 B 相比,b;OR:1.77;95%CI:1.24-2.54)、显性模型(bb+Bb 与 BB 相比,OR:2.04;95%CI:1.32-3.16)和杂合模型(Bb 与 BB 相比,OR:1.97;95%CI:1.26-3.09)中 MCI 的发病风险增加有关。相反,ApaI 多态性在所有模型中对 MCI 均有保护作用。显性模型(tt+Tt 与 TT 相比,OR:1.44;95%CI:1.17-1.79)和纯合模型(tt 与 TT 相比,OR:1.43;95%CI:1.02-2.00)表明 VDR 基因的 TaqI 多态性与 AD 的发病风险增加有关,尤其是在白种人群中。Egger 线性回归检验未发现发表偏倚。这项荟萃分析表明,VDR ApaI 和 BsmI 以及 TaqI 基因多态性可能分别是 MCI 和 AD 的重要预测因子,但存在人群差异。需要进一步的研究来进一步证实这些关联,特别是要考虑基因-基因相互作用、基因-环境相互作用和其他混杂因素。